1378 Preclinical Characterization of IMGS-001, a Dual Antagonist Anti-Pd-l1, Anti-Pd-l2 Antibody with Effector Function, to Treat Patients Resistant to Immune Checkpoint Blockade
Regular and Young Investigator Award Abstracts（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要